These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11264362)

  • 21. The bifurcated stem loop 4 (SL4) is crucial for efficient packaging of mouse mammary tumor virus (MMTV) genomic RNA.
    Mustafa F; Vivet-Boudou V; Jabeen A; Ali LM; Kalloush RM; Marquet R; Rizvi TA
    RNA Biol; 2018; 15(8):1047-1059. PubMed ID: 29929424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complementarity-directed RNA dimer-linkage promotes retroviral recombination in vivo.
    Mikkelsen JG; Rasmussen SV; Pedersen FS
    Nucleic Acids Res; 2004; 32(1):102-14. PubMed ID: 14715920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficient dimerization of human immunodeficiency virus type 1 RNA caused by mutations of the u5 RNA sequences.
    Russell RS; Hu J; Laughrea M; Wainberg MA; Liang C
    Virology; 2002 Nov; 303(1):152-63. PubMed ID: 12482667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis of stem-loops in the RNA packaging signal of the Moloney murine leukemia virus.
    Fisher J; Goff SP
    Virology; 1998 Apr; 244(1):133-45. PubMed ID: 9581786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1.
    Darlix JL; Gabus C; Nugeyre MT; Clavel F; Barré-Sinoussi F
    J Mol Biol; 1990 Dec; 216(3):689-99. PubMed ID: 2124274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression.
    Stenbak CR; Linial ML
    J Virol; 2004 Sep; 78(17):9423-30. PubMed ID: 15308736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env.
    Bansal A; Shaw KL; Edwards BH; Goepfert PA; Mulligan MJ
    J Virol; 2000 Mar; 74(6):2949-54. PubMed ID: 10684317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gene expression of human foamy virus does not require a post-transcriptional transactivator.
    Lee AH; Lee HY; Sung YC
    Virology; 1994 Oct; 204(1):409-13. PubMed ID: 7522374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis.
    Müllers E; Uhlig T; Stirnnagel K; Fiebig U; Zentgraf H; Lindemann D
    J Virol; 2011 Feb; 85(4):1452-63. PubMed ID: 21106749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions.
    Ooms M; Huthoff H; Russell R; Liang C; Berkhout B
    J Virol; 2004 Oct; 78(19):10814-9. PubMed ID: 15367648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human foamy virus reverse transcription that occurs late in the viral replication cycle.
    Moebes A; Enssle J; Bieniasz PD; Heinkelein M; Lindemann D; Bock M; McClure MO; Rethwilm A
    J Virol; 1997 Oct; 71(10):7305-11. PubMed ID: 9311807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.
    Shehu-Xhilaga M; Crowe SM; Mak J
    J Virol; 2001 Feb; 75(4):1834-41. PubMed ID: 11160682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of human foamy virus reverse transcriptase involves a spliced pol mRNA.
    Jordan I; Enssle J; Güttler E; Mauer B; Rethwilm A
    Virology; 1996 Oct; 224(1):314-9. PubMed ID: 8862427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequences in pol are required for transfer of human foamy virus-based vectors.
    Erlwein O; Bieniasz PD; McClure MO
    J Virol; 1998 Jul; 72(7):5510-6. PubMed ID: 9621007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro dimerization of HIV-2 leader RNA in the absence of PuGGAPuA motifs.
    Berkhout B; Essink BB; Schoneveld I
    FASEB J; 1993 Jan; 7(1):181-7. PubMed ID: 8422965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains.
    Kögel D; Aboud M; Flügel RM
    Virology; 1995 Oct; 213(1):97-108. PubMed ID: 7483284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long terminal repeat U3 length polymorphism of human foamy virus.
    Schmidt M; Herchenröder O; Heeney J; Rethwilm A
    Virology; 1997 Apr; 230(2):167-78. PubMed ID: 9143272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the contribution of reverse transcriptase and integrase proteins to retroviral RNA dimer conformation.
    Buxton P; Tachedjian G; Mak J
    J Virol; 2005 May; 79(10):6338-48. PubMed ID: 15858017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HIV plus-strand transfer reaction: determination of replication-competent intermediates and identification of a novel lentiviral element, the primer over-extension sequence.
    Muthuswami R; Chen J; Burnett BP; Thimmig RL; Janjic N; McHenry CS
    J Mol Biol; 2002 Jan; 315(3):311-23. PubMed ID: 11786014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic activity, the carboxy terminus of Gag, and the primer binding site are not required for Pol incorporation into foamy virus particles.
    Baldwin DN; Linial ML
    J Virol; 1999 Aug; 73(8):6387-93. PubMed ID: 10400731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.